Myeloma Crowd Radio: Using Nanotechnology in Multiple Myeloma

Nanotecnology is the study of very small things - won to the atom and molecule level. Researchers at Washingon University have been given a prestigious grant by the NIH to study nanotechnology in cancer and more specifcially, in multiple myeloma. Nanotechnology can deliver a higher concentration (by a hundred fold) of drug in a more targeted way. It can also usie imaging testing (like PET/CT) and MRI to find and selectively target cancerous cells. It can also help kick hiding myeloma cells out into the blood which can then be killed by myeloma drugs. This is a groundbreaking use of new technolgoy in cancer with a team of top experts.